CD81 通过阻断 CD274/PD-L1 的选择性自噬降解驱动放射抵抗性胶质母细胞瘤的免疫逃逸
CD81 drives immune evasion in radioresistant glioblastoma by blocking selective autophagic degradation of CD274/PD-L1.
我们的工作确立了CD81作为连接放射抵抗与免疫逃逸的关键桥梁,其通过维持GBM中CD274的丰度发挥作用,并突显CD81作为优化放射免疫治疗的有前景的治疗靶点。
英文原题:A Quantitative Digital Analysis of Tissue Immune Components Reveals an Immunosuppressive and Anergic Immune Response with Relevant Prognostic Significance in Glioblastoma.
结果:所有GBM均为IDH野生型,其中根据EGFR扩增情况,一部分为经典型GBM(44%)。
目的:免疫检查点阻断等免疫刺激治疗对部分胶质母细胞瘤(GBM)患者具有临床活性。多种抑制机制会显著影响GBM免疫应答。本研究旨在分析肿瘤免疫微环境及其临床意义,并定量检测若干相关免疫生物标志物。设计:研究76例具有充分临床随访资料的原发(非复发)GBM,其中部分患者接受树突状细胞疫苗治疗。检测IDH突变、EGFR扩增和MGMT甲基化状态,并通过数字图像分析和半定量评估,在代表性区域定量CD163、CD8、PD-1和PD-L1等免疫标志物。各项免疫表达比例按肿瘤细胞总数计算。结果:所有GBM均为IDH野生型;按EGFR扩增状态,44%属于经典型GBM。形态学观察发现CD163免疫染色阳性小胶质细胞和瘤内巨噬细胞簇。CD8表达与淋巴细胞免疫抑制机制显著正相关;CD8水平越高,CD163(p<0.001)、PD-L1(p=0.026)及PD-1(p=0.007)水平越高。多变量分析显示,CD8阳性细胞高表达(HR=2.05,95% CI 1.02–4.13,p=0.034)及CD163阳性细胞高表达(HR=2.50,95% CI 1.29–4.85,p=0.007)均与较短生存相关。非经典型(无EGFR扩增)GBM中免疫标志物表达更高。其他重要预后因素包括年龄、是否接受DC疫苗及MGMT甲基化状态。结论:CD8浸润与生存呈负相关,效应细胞与CD163巨噬细胞及免疫检查点表达呈正相关。作者据此推测,浸润的CD8细胞可能处于无反应状态或淋巴细胞功能低下。组织中CD163水平与生存显著负相关,说明此类免疫细胞对形成强免疫抑制环境具有重要意义。这些信息可能有助于筛选适合接受免疫治疗的患者。
Objectives: Immunostimulatory therapies using immune checkpoint blockers show clinical activity in a subset of glioblastoma (GBM) patients. Several inhibitory mechanisms play a relevant role in the immune response to GBM. With the objective of analyzing the tumor immune microenvironment and its clinical significance, we quantified several relevant immune biomarkers. Design: We studied 76 primary (non-recurrent) GBMs with sufficient clinical follow-up, including a subgroup of patients treated with a dendritic cell vaccine. The IDH-mutation, EGFR-amplification, and MGMT methylation statuses were determined. Several relevant immune biomarkers, including CD163, CD8, PD1, and PDL1, were quantified in representative selected areas by digital image analysis and semiquantitative evaluation. The percentage of each immune expression was calculated with respect to the total number of tumor cells. Results: All GBMs were wild-type IDH, with a subgroup of classical GBMs according to the EGFR amplification (44%). Morphologically, CD163 immunostained microglia and intratumor clusters of macrophages were observed. A significant direct correlation was found between the expression of CD8 and the mechanisms of lymphocyte immunosuppression, in such a way that higher values of CD8 were directly associated with higher values of CD163 (p < 0.001), PDL1 (0.026), and PD1 (0.007). In a multivariate analysis, high expressions of CD8+ (HR = 2.05, 95%CI (1.02−4.13), p = 0.034) and CD163+ cells (HR 2.50, 95%CI (1.29−4.85), p = 0.007), were associated with shorter survival durations. The expression of immune biomarkers was higher in the non-classical (non-EGFR amplified tumors) GBMs. Other relevant prognostic factors were age, receipt of the dendritic cell vaccine, and MGMT methylation status. Conclusions: In accordance with the inverse correlation between CD8 and survival and the direct correlation between effector cells and CD163 macrophages and immune-checkpoint expression, we postulate that CD8 infiltration could be placed in a state of anergy or lymphocytic inefficient activity. Furthermore, the significant inverse correlation between CD163 tissue concentration and survival explains the relevance of this type of immune cell when creating a strong immunosuppressive environment. This information may potentially be used to support the selection of patients for immunotherapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。